New injection tested to regrow hair in severe alopecia
NCT ID NCT07311564
Summary
This study is testing an investigational drug called LAD603 to see if it helps regrow hair in adults with severe to very severe alopecia areata, an autoimmune condition that causes hair loss. About 136 participants will receive either LAD603 or a placebo injection to compare hair regrowth and safety. The main goal is to measure the change in scalp hair loss using a standard scoring tool.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Investigator Site 1
RECRUITINGOmaha, Nebraska, 68144, United States
Conditions
Explore the condition pages connected to this study.